Sangrix restates interim financials after correcting share classification and warrant dividend errors
SGRX•Interim financials restated
Sangrix filed a Form 6-K/A restating interim financial statements for the six months ended Dec. 31, 2025.
The restatement was deemed material under SEC Staff Accounting Bulletin No. 99.
Accounting reclassifications and loss impact
The company reclassified certain redeemable Class A ordinary shares from permanent equity to mezzanine equity, shifting US$4.2 million within equity.
It also recast convertible debenture items under the fair value option, with no change to consolidated net loss.
Sangrix reduced the deemed dividend from warrant down-round features to US$7.73 million, lifting loss attributable to Sangrix to US$16.4 million.
